Rigel Pharmaceuticals (RI2.F) Q2 2024 Earnings

7MayConfirmed
Q2 2024
-0.47
-0.4
-0.33
-0.27

Details

Expected EPS
-0.26780838
Actual EPS
-0.465
Surprise EPS
-0.2
Surprise Percent
+73.63%

Description

Rigel Pharmaceuticals (RI2.F) has reported earnings of -0.465 per share for Q2 2024.

0 Comments

Share your thoughts